Partnering with the 8th Oncolytic Virotherapy Summit is your opportunity to demonstrate expertise, elevate your brand, and establish yourself as a key thought leader and front runner within the immune-oncology community. Your brand, your message, and your reputation showcased in front of translational and clinical experts from the field of OV development.

With a wealth of investment, innovation and critical clinical data emerging from within the immune-oncology space, and an ever-increasing number of companies launching new OV candidates into pre-clinical and clinical studies, there is a unique opportunity for pre-clinical CROs, adjuvant formulators, peptide providers, and immune reagent suppliers to establish themselves as the go-to commercial partners for the industry. We will work with you to build bespoke partnerships to ensure you meet your 2024 business objectives.

Get in touch today to learn more about how we can support you and your commercial goals within the field of Oncolytic viruses